about
Hepatitis B and human immunodeficiency virus co-infectionClinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patientsOccult Hepatitis B Virus Infection among HIV Positive Patients in NigeriaPrevalence of occult HBV infection in haemodialysis patients with chronic HCV.Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women.Viral hepatitis in HIV infection.HIV-HBV coinfection among South African patients receiving antiretroviral therapy.Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.The prevalence of hepatitis B co-infection in a South African urban government HIV clinic.Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South AfricaGenomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individualsHigh seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda.Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance.Management and treatment of hepatitis B virus in patients with HIV infection: A practical guide for health care professionals.Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infectionOccult Hepatitis B (OBH) in Clinical Settings.Limited infection with occult hepatitis B virus in drug users in the USA.Hepatocellular cancer in HIV-infected individuals: tomorrow's problem?Prevalence of hepatitis B surface antigen seropositivity among HIV-infected and non-infected individuals in Nnewi, NigeriaIncidence of transaminitis among HIV-infected patients with occult hepatitis BPrevalence of occult hepatitis B virus infection in hemodialysis patients in Isfahan, Iran.Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations.Vaccination against viral hepatitis of HIV-1 infected patients.Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study.Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.Liver involvement in human immunodeficiency virus infection.Occult HBV infection status among chronic hepatitis C and hemodialysis patients in Northeastern Egypt: regional and national overview.Blood-borne viral co-infections among human immunodeficiency virus-infected inmates.Occult hepatitis B infection in different high risk patients.Characterization of overt and occult hepatitis B virus infection among HTLV-1 positive healthy carriers in the Northeast of Iran; AN HTLV-I endemic area.Isolated anti-HBc among HIV-infected patients in Istanbul, Turkey.Very low prevalence and no clinical significance of occult hepatitis B in a cohort of HIV-infected patients with isolated anti-HBc seropositivity: the BHOI study."Anti-HBc alone" in human immunodeficiency virus-positive and immuno-suppressed lymphoma patients.Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: overt and occult infection.Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen.Prevalence of Hepatitis B virus and/or Hepatitis C virus co-infections in prisoners infected with the Human Immunodeficiency Virus.Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003.High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants.
P2860
Q26822862-52778D46-1DD0-4D5D-BBDA-909B19316DB2Q27488236-E25D9EA4-BC02-4EC7-A833-2CD4EAC8911FQ33607322-DC096781-69F0-47C1-A08C-21C4B0579851Q33867994-C74A8BCA-F2E1-480E-AAEA-1D1EA7C910D0Q34080934-FFAECB9F-6DA5-4282-A222-72A704C9366FQ34086980-89E189AB-9835-47CD-AD97-569E69090CF6Q34401948-DA6B19F4-9CC9-46FD-9697-5BD495448515Q34405008-A40F2FF1-F529-4F81-B390-CB0B4C0059A1Q34432918-087A8D39-E370-40FB-8AE2-19057B8BC00BQ34437586-3961ED0A-3799-4479-B4A2-BFA26C022EC4Q34468872-745CA3A4-0501-4E19-9F1E-F8A8461520ACQ34544546-F1A9FFCA-8DCD-48A5-9DCB-4F83B82B62E1Q34743962-1C3E1D59-CB86-4F4F-AAB4-74709B86133AQ35063655-DA0CDD7F-4FE7-463F-8D61-BB0AAE3B5587Q35127050-9507BCC3-3D83-40A0-ABD9-4686339ACABDQ35433965-7C89622E-0750-4784-A300-E8B6DBC1DF20Q35990074-B677E188-A611-4500-AAC7-DD29234D956EQ36328982-88BF9462-82BF-4DC6-A60D-B7173008D187Q36420099-B2FCE200-44F8-4599-9FD1-EF6748B0E7D4Q36668229-FAC486E7-0945-4401-B0EA-0DC093EAC932Q36806193-D2541BFB-58FC-4300-8566-D544B37CDC0FQ36952181-09F97C16-5EAD-4F2B-8AE0-F3BBD3838D5BQ37304270-0B66CA16-2D4C-40D0-80D1-85F196EA8102Q37587663-D033924F-1903-4D5F-B578-38BACC8B789BQ38013507-EED0E2BF-EE95-44B1-9B93-33811EC6F78EQ38597807-5BE9B3F2-0666-4BB4-A2A5-C3BB7F6AA453Q38782188-909CFDE7-7F43-4250-B416-14080A580324Q38852184-83AE36A3-5F91-4189-8F0F-C26C0C635117Q39210168-87E1A25B-E47A-4E3B-94E0-C99966E5B059Q39739900-74363BA2-41B9-4A9A-8C41-0016CDA1A91EQ41944202-CC51F207-1869-4322-8545-F9518E0AFA42Q42199389-EDED7D4B-4FFB-4240-A406-0F2DA20A012AQ42276730-66E37639-AEB1-4FF9-85F4-EE67B2AA233CQ42602090-0B3FE00D-FD43-4EC5-9AAF-C2DC8453A55FQ43070377-DC52F716-38B5-4D9F-A528-C593B36F2BADQ43498043-2437207E-B167-489A-B8C6-92A69903F9E8Q43926418-8BCA4A17-CE03-49AA-8275-E9AA6251EF34Q44038833-A84883D9-0745-479D-82D7-E879A4C40E1BQ44496767-B9D482C2-01A9-4C48-B5E3-38EA5174A81FQ45363371-EEC81644-CC48-4C3D-8D7B-2F3C34B87344
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Occult hepatitis B in HIV-infected patients.
@en
Occult hepatitis B in HIV-infected patients.
@nl
type
label
Occult hepatitis B in HIV-infected patients.
@en
Occult hepatitis B in HIV-infected patients.
@nl
prefLabel
Occult hepatitis B in HIV-infected patients.
@en
Occult hepatitis B in HIV-infected patients.
@nl
P2093
P1476
Occult hepatitis B in HIV-infected patients.
@en
P2093
Kenneth E Sherman
Natasa Rajicic
Norah J Shire
Susan D Rouster
P304
P356
10.1097/00126334-200407010-00015
P407
P577
2004-07-01T00:00:00Z